Stock listing

NASDAQ:BPMC Blueprint Medicines Corp Stock

Follow Blueprint Medicines Corp into a list and get an email when it puts out news.

Last close · NASDAQ:BPMC

$129.46 USD

Close on Jul 17, 2025 · No longer trades

Apr 30, 2015 to last close +586.1% · monthly closes, Apr 30, 2015 – Jul 17, 2025
Lowest – highest close
$13.34 – $129.46 USDSince Apr 30, 2015 · lowest Feb 8, 2016 · highest Jul 17, 2025

Delisted NASDAQ:BPMC no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:BPMC
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Blueprint Medicines Corp on 6ix

Calls
17 calls with a replay · 17 with a transcript · latest May 1, 2025
Decks
50 decks · latest May 1, 2025

Events

CallWhenStatus
Blueprint Medicines (BPMC) Q1 2025 Earnings CallWed, Apr 30, 2025 · 10:00 PM ETReplay
Blueprint Medicines (BPMC) Q4 2024 Earnings CallThu, Feb 13, 2025 · 8:00 AM ETReplay
Blueprint Medicines (BPMC) Q3 2024 Earnings CallWed, Oct 30, 2024 · 8:00 AM ETReplay
Blueprint Medicines (BPMC) Q2 2024 Earnings CallThu, Aug 01, 2024 · 8:00 AM ETReplay
Blueprint Medicines (BPMC) Q1 2024 Earnings CallThu, May 02, 2024 · 8:00 AM ETReplay
Blueprint Medicines (BPMC) Q4 2023 Earnings CallMon, Mar 04, 2024 · 9:10 AM ETReplay
Blueprint Medicines (BPMC) Q3 2023 Earnings CallThu, Oct 26, 2023 · 8:00 AM ETReplay
Blueprint Medicines (BPMC) Q2 2023 Earnings CallWed, Aug 02, 2023 · 8:00 AM ETReplay
Blueprint Medicines (BPMC) Q1 2023 Earnings CallThu, May 04, 2023 · 8:00 AM ETReplay
Blueprint Medicines (BPMC) Q4 2022 Earnings CallThu, Feb 16, 2023 · 8:00 AM ETReplay
All 17 calls
CallWhenStatus
Blueprint Medicines (BPMC) Q2 2022 Earnings CallTue, Aug 02, 2022 · 8:00 AM ETReplay
Blueprint Medicines (BPMC) Q1 2022 Earnings CallTue, May 03, 2022 · 8:30 AM ETReplay
Blueprint Medicines (BPMC) Q4 2021 Earnings CallWed, Feb 16, 2022 · 8:30 AM ETReplay
Blueprint Medicines (BPMC) Q3 2021 Earnings CallThu, Oct 28, 2021 · 8:30 AM ETReplay
Blueprint Medicines (BPMC) Q2 2021 Earnings CallTue, Aug 10, 2021 · 8:30 AM ETReplay
Blueprint Medicines (BPMC) Q1 2021 Earnings CallThu, Apr 29, 2021 · 8:30 AM ETReplay
Blueprint Medicines (BPMC) Q4 2020 Earnings CallWed, Feb 17, 2021 · 8:30 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Q1 2025 Earnings PresentationEarnings14 slidesMay 1, 2025
Q4 2024 Earnings PresentationEarnings12 slidesFeb 13, 2025
J.P. Morgan Healthcare Conference 2025Conference25 slidesJan 13, 2025
Technical Presentation (April 2024)Technical19 slidesApr 25, 2024
J.P. Morgan Healthcare Conference 2024Conference25 slidesJan 8, 2024
AAAAI 2023 Annual MeetingConference35 slidesFeb 27, 2023
FY2022 Earnings PresentationEarnings13 slidesFeb 16, 2023
J.P. Morgan Healthcare Conference 2023Conference28 slidesJan 9, 2023
Investor Day (November 2022)Investor day113 slidesNov 1, 2022
Investor Presentation (September 2022)Investor deck24 slidesSep 7, 2022
All 50 decks
DeckKindSlidesDate
PIONEER Part 2 Top-line Results call (August 2022)Conference19 slidesAug 17, 2022
Corporate Update (June 2022)Corporate update6 slidesJun 30, 2022
Jefferies Healthcare Conference 2022Conference24 slidesJun 9, 2022
Technical Presentation (April 2022)Technical27 slidesApr 8, 2022
Investor Presentation (January 2022)Investor deck39 slidesJan 10, 2022
Merger or Acquisition (November 2021)Merger or acquisition8 slidesNov 29, 2021
AACR Annual Meeting 2021Conference26 slidesApr 12, 2021
Investor Presentation (January 2021)Investor deck29 slidesJan 11, 2021
Investor Presentation (September 2020)Investor deck18 slidesSep 22, 2020
ASCO 2020 Virtual MeetingConference21 slidesMay 29, 2020
Corporate Update (April 2020)Corporate update8 slidesApr 28, 2020
Corporate Update (April 2020)Corporate update31 slidesApr 1, 2020
Corporate Update (March 2020)Corporate update43 slidesMar 16, 2020
J.P. Morgan Healthcare Conference 2020Conference35 slidesJan 13, 2020
ASH 2019 Annual MeetingConference31 slidesDec 9, 2019
Investor Day (November 2019)Investor day127 slidesNov 5, 2019
Corporate Update (June 2019)Corporate update21 slidesJun 17, 2019
European Hematology Association Annual Meeting 2019Conference19 slidesJun 17, 2019
2019 ASCO Annual MeetingConference45 slidesJun 4, 2019
Technical Presentation (June 2019)Technical18 slidesJun 3, 2019
Investor Presentation (January 2019)Investor deck31 slidesJan 7, 2019
American Society of Hematology Annual Meeting 2018Conference18 slidesDec 3, 2018
CTOS 2018 Annual MeetingConference33 slidesNov 15, 2018
Connective Tissue Oncology Society 2018 Annual MeetingConference16 slidesNov 15, 2018
Technical Presentation (October 2018)Technical16 slidesOct 1, 2018
2018 AACR Annual MeetingConference44 slidesApr 16, 2018
Technical Presentation (April 2018)Technical25 slidesApr 16, 2018
Investor Presentation (January 2018)Investor deck27 slidesJan 8, 2018
Technical Presentation (November 2017)Technical13 slidesNov 13, 2017
Technical Presentation (September 2017)Technical16 slidesSep 11, 2017
Investor Presentation (August 2017)Investor deck25 slidesAug 9, 2017
Technical Presentation (June 2017)Technical19 slidesJun 6, 2017
2017 ASCO Annual MeetingConference41 slidesJun 6, 2017
Investor Presentation (April 2017)Investor deck31 slidesApr 5, 2017
Investor Presentation (January 2017)Investor deck31 slidesJan 9, 2017
2016 American Society of Hematology (ASH) Annual MeetingConference25 slidesDec 5, 2016
American Society of Hematology Annual Meeting 2016Conference18 slidesDec 5, 2016
EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium 2016Conference17 slidesDec 1, 2016
Technical Presentation (December 2016)Technical39 slidesDec 1, 2016
Investor Presentation (January 2016)Investor deck19 slidesJan 11, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Daniel Lynch
Other companies: TCGX Acquisition Corp. (Chairman of the TriGemX Bio Board of Directors · Since Nov 9, 2026); SpringWorks Therapeutics Inc (Director · Since at least Sep 12, 2019); Xilio Therapeutics, Inc. (Director · Oct 21, 2021 – Oct 21, 2021 · Past); 2Seventy Bio Inc (Director · Oct 18, 2021 – Jun 13, 2023 · Past); Omega Alpha SPAC (Director · Jan 6, 2021 – Jan 6, 2021 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Dec 31, 2020 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – Jun 19, 2019 · Past); Surface Oncology Inc (Director · Apr 18, 2018 – Jun 10, 2020 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – May 19, 2017 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 9, 2015 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Nov 11, 2021 · Past)
Director · Apr 30, 2015 – Jun 24, 2020 · Past
Alexis Borisy
Other companies: Parabilis Medicines, Inc. (Lead Independent Director; Chairman, Nextech Invest; Chairman, Curie.Bio · Since at least Jun 9, 2026); Tango Therapeutics, Inc. (Director · Since at least Aug 10, 2021); Relay Therapeutics, Inc. (Director · Since at least Jul 15, 2020); Revolution Medicines, Inc. (Director · Since at least Feb 12, 2020); OPKO Health, Inc. (Director · May 9, 2022 – Jun 22, 2023 · Past); EQRx Inc (Executive Chairman, Director · Dec 17, 2021 – Nov 9, 2023 · Past); Dianthus Therapeutics, Inc. (Director · Jun 20, 2018 – Aug 26, 2021 · Past); Editas Medicine, Inc. (Director · Feb 2, 2016 – Jun 15, 2017 · Past); Foundation Medicine Inc (Director · Sep 24, 2013 – Jul 31, 2018 · Past); EPIRUS Biopharmaceuticals Inc (CEO & President, Director · Jan 26, 2006 – Jan 26, 2009 · Past)
Director · Since at least Apr 30, 2015
Charles A Rowland Jr
Other companies: Generation Bio Co (Director · Since at least Jun 11, 2020); Viking Therapeutics, Inc. (Director · Since at least Jul 1, 2017); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 3, 2022 · Past); Vitae Pharmaceuticals Inc (Director · Sep 24, 2014 – Oct 25, 2016 · Past); BIND Therapeutics Inc (Director · May 28, 2014 – Jun 21, 2016 · Past); Idenix Pharmaceuticals Inc (Director · Jun 6, 2013 – Aug 5, 2014 · Past); Viropharma Inc (VP, Chief Financial Officer · Oct 20, 2008 – Jan 24, 2014 · Past)
Director · Apr 30, 2015 – Jun 2, 2021 · Past
Habib Joseph Dable
Other companies: Tyra Biosciences, Inc. (Director · Since at least Apr 16, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Relay Therapeutics, Inc. (Director · Since at least Nov 4, 2025); Day One Biopharmaceuticals Inc (Director · Since at least Jan 17, 2024); PepGen Inc. (Director · Since at least Sep 20, 2022); Jade Biosciences, Inc. (Director · Jul 10, 2023 – Jun 5, 2024 · Past); Albireo Pharma Inc (Director · Aug 8, 2022 – Mar 2, 2023 · Past); Acceleron Pharma Inc (CEO and President, Director · Jan 4, 2021 – Nov 19, 2021 · Past)
Director · Since at least Jun 23, 2022
Mark Alan Goldberg
Other companies: Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past)
Director · Since at least Jun 25, 2015
Daniella Beckman
Other companies: Upstream Bio, Inc. (Member, Board of Directors · Since at least Oct 10, 2024); Tango Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 10, 2021); Vor Biopharma Inc. (Chair of the Audit Committee · Since at least Feb 4, 2021); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Translate Bio Inc (Director · Jun 18, 2019 – Sep 14, 2021 · Past)
Director · Since at least Dec 8, 2021
Lonnel Coats
Other companies: Mineralys Therapeutics, Inc. (Board Member · Since at least Oct 19, 2026); Relay Therapeutics, Inc. (Director · Since at least Nov 4, 2025); Verve Therapeutics Inc (Director · Since at least Aug 8, 2022); Lexicon Pharmaceuticals, Inc. (Chief Executive Officer, Director · Jul 7, 2014 – Feb 28, 2024 · Past)
Director · Since at least Feb 3, 2016
Christina Rossi
Other companies: CG Oncology, Inc. (Biopharmaceutical Executive & Board Member · Since at least Nov 24, 2025); Xilio Therapeutics, Inc. (Director · Since at least Oct 21, 2021); Anika Therapeutics Inc. (Director · Until Apr 15, 2026 · Past)
Chief Operating Officer · Since at least Oct 29, 2018
Jeffrey Albers
Other companies: Spyre Therapeutics, Inc. (Director · Since at least Nov 22, 2023); Kymera Therapeutics, Inc. (Director · Since at least Aug 20, 2020); Dianthus Therapeutics, Inc. (Director · Jun 20, 2018 – Jun 28, 2022 · Past)
Director · Since at least Apr 30, 2015
Kate Haviland
Other companies: Avalyn Pharma Inc. (Director · Since at least Apr 29, 2026); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Fulcrum Therapeutics, Inc. (Director · Since at least Jul 17, 2019)
Chief Executive Officer, Director · Since at least Jan 5, 2016
All 27 people
PersonSeat
Lynn Seely
Other companies: AbCellera Biologics Inc. (Director · Since at least Jun 30, 2026); Lyell Immunopharma, Inc. (President and CEO, Director · Since at least Jun 16, 2021); Myovant Sciences Ltd (Principal Executive Officer, Director · Apr 5, 2019 – Apr 3, 2020 · Past)
Director · Since at least Jun 19, 2019
Fouad Namouni
Other companies: Vor Biopharma Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least Apr 30, 2024); Aprea Therapeutics, Inc. (Director · Jun 26, 2020 – Jun 30, 2021 · Past)
PRESIDENT, R & D · Since at least Sep 1, 2020
George Demetri
Other companies: Translate Bio Inc (Director · Jul 12, 2019 – Sep 14, 2021 · Past); Merrimack Pharmaceuticals Inc (Director · Nov 29, 2017 – Jun 13, 2018 · Past)
Director · Apr 30, 2015 – Jun 21, 2022 · Past
Kyle Kuvalanka
Other companies: Aktis Oncology, Inc. (Chief Financial Officer · Since at least Jan 8, 2026); Syros Pharmaceuticals, Inc. (Chief Operating Officer · Jun 29, 2016 – Feb 10, 2017 · Past)
Chief Business Officer · Apr 30, 2015 – Apr 30, 2015 · Past
Philina Lee
Other companies: DBV Technologies SA (Board Member · Since at least Oct 30, 2025); Fusion Pharmaceuticals Inc (Director · Feb 11, 2021 – Jun 4, 2024 · Past)
Chief Commercial Officer · Since at least Apr 4, 2022
Tracey McCain
Other companies: Kiniksa Pharmaceuticals International, plc (Director · Since at least May 23, 2018); ImmunoGen Inc (Director · Nov 15, 2021 – Feb 12, 2024 · Past)
EVP & Chief Legal Officer · Since at least Sep 6, 2016
Becker Hewes
Other companies: Damora Therapeutics, Inc. (Chief Medical Officer · Since at least Jan 5, 2026)
Chief Medical Officer · Since at least Jan 11, 2021
Christoph Lengauer
Other companies: Hookipa Pharma Inc (Director · Apr 17, 2019 – Jun 1, 2021 · Past)
Chief Scientific Officer · Apr 29, 2015 – Apr 13, 2016 · Past
Michael Landsittel
Other companies: Damora Therapeutics, Inc. (Board Director · Since at least Mar 23, 2026)
Chief Financial Officer · Since at least Aug 11, 2015
Nicholas Lydon
Other companies: AnaptysBio, Inc. (Director · Jan 25, 2017 – Feb 8, 2019 · Past)
Director · Apr 30, 2015 – Jun 12, 2024 · Past
Anthony L BoralChief Medical Officer · Nov 6, 2017 – Dec 14, 2020 · Past
Ariel HurleyPrincipal Accounting Officer · Since at least Mar 6, 2019
Christopher K MurrayCHIEF TECHNICAL OPERATIONS · Oct 10, 2017 – Mar 7, 2024 · Past
Debra Durso-BumpusChief People Officer · Since at least Feb 10, 2020
John TsaiDirector · Since at least Jan 6, 2023
Marion DorschChief Scientific Officer · Nov 21, 2016 – Feb 22, 2021 · Past
Percy H CarterChief Scientific Officer · Since at least May 19, 2021

Open People

Log in to ask 6ix AI your own questions about Blueprint Medicines Corp.